Edison Kazumi Miyawaki, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Telencephalon | 1 | 2023 | 142 | 0.820 |
Why?
|
| Brain Stem | 1 | 2023 | 857 | 0.590 |
Why?
|
| Leukemia, Plasma Cell | 1 | 2017 | 46 | 0.560 |
Why?
|
| Globus Pallidus | 4 | 2000 | 249 | 0.380 |
Why?
|
| Headache | 1 | 2017 | 1249 | 0.320 |
Why?
|
| Seizures | 1 | 2017 | 2917 | 0.230 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2024 | 65 | 0.220 |
Why?
|
| Substantia Innominata | 1 | 2023 | 23 | 0.220 |
Why?
|
| Granuloma, Plasma Cell | 1 | 2021 | 80 | 0.180 |
Why?
|
| Hallucinations | 1 | 2023 | 366 | 0.180 |
Why?
|
| Dendrites | 1 | 2023 | 475 | 0.180 |
Why?
|
| Parkinson Disease | 5 | 2000 | 2859 | 0.170 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2021 | 286 | 0.160 |
Why?
|
| Cognition | 4 | 2000 | 6957 | 0.160 |
Why?
|
| Parietal Lobe | 1 | 2023 | 850 | 0.150 |
Why?
|
| Haloperidol | 2 | 1996 | 389 | 0.140 |
Why?
|
| Borderline Personality Disorder | 2 | 1995 | 765 | 0.140 |
Why?
|
| Edema | 1 | 2020 | 769 | 0.140 |
Why?
|
| Muscular Diseases | 1 | 2020 | 551 | 0.130 |
Why?
|
| Leg | 1 | 2020 | 1090 | 0.130 |
Why?
|
| Stiff-Person Syndrome | 1 | 1994 | 32 | 0.120 |
Why?
|
| Amyloidosis | 1 | 2020 | 817 | 0.110 |
Why?
|
| Tourette Syndrome | 1 | 1996 | 394 | 0.110 |
Why?
|
| Dystonia | 1 | 1996 | 364 | 0.110 |
Why?
|
| Anger | 1 | 1995 | 401 | 0.100 |
Why?
|
| Autoimmune Diseases | 1 | 2024 | 2250 | 0.100 |
Why?
|
| Fluoxetine | 1 | 1995 | 733 | 0.090 |
Why?
|
| Hyperthyroidism | 2 | 1994 | 291 | 0.090 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 1993 | 269 | 0.090 |
Why?
|
| Electric Stimulation | 4 | 2000 | 1735 | 0.070 |
Why?
|
| Thyroid Function Tests | 1 | 1988 | 289 | 0.070 |
Why?
|
| Pain | 1 | 2020 | 5066 | 0.060 |
Why?
|
| Child Abuse | 1 | 1993 | 1067 | 0.060 |
Why?
|
| Electric Stimulation Therapy | 2 | 2002 | 613 | 0.060 |
Why?
|
| Antipsychotic Agents | 2 | 1996 | 3061 | 0.050 |
Why?
|
| Hypothyroidism | 1 | 1988 | 665 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 12965 | 0.050 |
Why?
|
| Tomography, Emission-Computed | 2 | 2002 | 1121 | 0.050 |
Why?
|
| Lorazepam | 2 | 1991 | 154 | 0.040 |
Why?
|
| Essential Tremor | 1 | 2002 | 157 | 0.040 |
Why?
|
| Anti-Anxiety Agents | 2 | 1993 | 397 | 0.040 |
Why?
|
| Nasopharynx | 1 | 2021 | 394 | 0.040 |
Why?
|
| Neuropsychological Tests | 3 | 2000 | 7021 | 0.040 |
Why?
|
| Brain | 3 | 2002 | 26951 | 0.040 |
Why?
|
| Gadolinium | 1 | 2021 | 959 | 0.030 |
Why?
|
| Tremor | 1 | 1997 | 187 | 0.030 |
Why?
|
| Humans | 22 | 2024 | 760621 | 0.030 |
Why?
|
| Adult | 8 | 2024 | 219994 | 0.030 |
Why?
|
| Thalamus | 2 | 2002 | 1041 | 0.030 |
Why?
|
| Comorbidity | 2 | 2024 | 10551 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 36290 | 0.030 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1993 | 174 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 2 | 2002 | 2733 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2000 | 2316 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2021 | 2007 | 0.030 |
Why?
|
| Neural Pathways | 2 | 2002 | 3040 | 0.030 |
Why?
|
| Visual Cortex | 1 | 2000 | 1089 | 0.030 |
Why?
|
| Urinary Bladder Diseases | 1 | 1993 | 169 | 0.020 |
Why?
|
| Female | 10 | 2024 | 391270 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2024 | 4166 | 0.020 |
Why?
|
| Gastrointestinal Motility | 1 | 1993 | 234 | 0.020 |
Why?
|
| Medicaid | 1 | 2024 | 2815 | 0.020 |
Why?
|
| Child Abuse, Sexual | 1 | 1993 | 392 | 0.020 |
Why?
|
| Hypotension, Orthostatic | 1 | 1993 | 256 | 0.020 |
Why?
|
| Contrast Media | 1 | 2021 | 5305 | 0.020 |
Why?
|
| Intestinal Diseases | 1 | 1993 | 506 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 1993 | 1201 | 0.020 |
Why?
|
| Nerve Net | 1 | 2000 | 2261 | 0.020 |
Why?
|
| Psychomotor Agitation | 1 | 1990 | 305 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2024 | 22053 | 0.020 |
Why?
|
| Aggression | 1 | 1991 | 745 | 0.020 |
Why?
|
| Male | 9 | 2024 | 359744 | 0.020 |
Why?
|
| Incidence | 1 | 2024 | 21392 | 0.020 |
Why?
|
| Thyroid Hormones | 1 | 1988 | 403 | 0.020 |
Why?
|
| Middle Aged | 7 | 2024 | 220352 | 0.020 |
Why?
|
| Autoantibodies | 1 | 1994 | 2118 | 0.020 |
Why?
|
| Psychotic Disorders | 2 | 1991 | 3193 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1995 | 6015 | 0.010 |
Why?
|
| Neurons | 2 | 2002 | 9426 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 1995 | 12427 | 0.010 |
Why?
|
| Electrodes, Implanted | 2 | 1997 | 833 | 0.010 |
Why?
|
| Ventral Thalamic Nuclei | 1 | 2002 | 43 | 0.010 |
Why?
|
| Anxiety Disorders | 1 | 1993 | 2714 | 0.010 |
Why?
|
| Adolescent | 2 | 2024 | 87810 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 2002 | 439 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1994 | 3455 | 0.010 |
Why?
|
| Subtraction Technique | 1 | 2002 | 510 | 0.010 |
Why?
|
| Aged | 4 | 2024 | 169152 | 0.010 |
Why?
|
| Young Adult | 1 | 2024 | 58741 | 0.010 |
Why?
|
| Electromyography | 1 | 2002 | 1388 | 0.010 |
Why?
|
| Paresthesia | 1 | 1997 | 162 | 0.010 |
Why?
|
| Age Factors | 1 | 1993 | 18416 | 0.010 |
Why?
|
| Verbal Behavior | 1 | 1997 | 335 | 0.010 |
Why?
|
| Prevalence | 1 | 1993 | 15687 | 0.010 |
Why?
|
| United States | 1 | 2024 | 72461 | 0.010 |
Why?
|
| Benzodiazepines | 2 | 1993 | 1131 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 2002 | 1420 | 0.010 |
Why?
|
| Behavior | 1 | 1997 | 540 | 0.010 |
Why?
|
| Receptors, Serotonin | 1 | 1993 | 208 | 0.010 |
Why?
|
| Bipolar Disorder | 1 | 1990 | 5078 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1997 | 1818 | 0.010 |
Why?
|
| Drug Therapy, Combination | 2 | 1991 | 6498 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 1991 | 553 | 0.010 |
Why?
|
| Receptors, GABA-A | 1 | 1993 | 621 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 1997 | 1878 | 0.010 |
Why?
|
| Visual Perception | 1 | 1997 | 1374 | 0.010 |
Why?
|
| Arousal | 1 | 1993 | 1157 | 0.000 |
Why?
|
| Animals | 1 | 2000 | 167963 | 0.000 |
Why?
|
| Brain Mapping | 1 | 2002 | 6568 | 0.000 |
Why?
|
| Child | 1 | 1993 | 79806 | 0.000 |
Why?
|
| Acute Disease | 1 | 1991 | 7269 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 1997 | 15840 | 0.000 |
Why?
|
| Depression | 1 | 1997 | 8044 | 0.000 |
Why?
|
| Prognosis | 1 | 1997 | 29658 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1997 | 39261 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1990 | 8056 | 0.000 |
Why?
|
| Hospitalization | 1 | 1991 | 10790 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 1997 | 65017 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1991 | 54303 | 0.000 |
Why?
|